Stock Screener App

Gratuito -

Installare

12.15

3.67% 0.43

Lyell Immunopharma Inc (LYEL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Lyell Immunopharma Inc Azioni (LYEL) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	14.29% 0.008	0.007	0.011	0.034	0.013
Operating Expenses	17.82% 47.15	57.37	201.16	50.54	51.54
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	17.82% 47.15	57.37	201.16	50.54	51.54
Operating Income/Loss	17.83% -47.14	-57.37	-201.15	-50.51	-51.53
Nonoperating Income/Loss	13.84% 4.456	5.172	9.212	5.922	5.719
Income/Loss From Continuing Operations Before Tax	14.29% 0.008	0.007	0.011	0.034	0.013
Income/Loss From Continuing Operations After Tax	18.22% -42.68	-52.20	-191.94	-44.58	-45.81
Net Income/Loss	18.22% -42.68	-52.20	-191.94	-44.58	-45.81
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	94.99% 14.79	295.10	6.157	256.31	255.40
Diluted Average Shares	94.99% 14.79	295.10	6.157	256.31	255.40
Basic Earnings Per Share	1,506% -2.89	-0.18	-0.72	-0.17	-0.18
Diluted Earnings Per Share	1,506% -2.89	-0.18	-0.72	-0.17	-0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters